Workforce Development

those materials designed to help the clinical workforce develop and strengthen knowledge and capabilities, may include manuals/guides, actual training programs/learning modules, and quick reference materials and tools.

Module 4: Pharmacotherapy for Alcohol Use Disorder

Describes and compares pharmacological treatment options for individuals with AUD, including FDA- approved medications acamprosate, disufiram, and naltrexone, as well as two other evidence-based treatments that are not yet FDA approved, topiramate and gabapentin; includes diagnosis of AUD, definitions of binge drinking and “at risk” drinking, and a case vignette; up to 1 AMA PRA Category 1 Credit™ for continuing education